Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds hormone or other secreted growth regulatory factor,...
Patent
1995-02-09
1999-11-30
Johnson, Nancy A.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds hormone or other secreted growth regulatory factor,...
4241451, 4241561, 4241381, 4241551, 5303871, 53038824, 5303892, 5303877, 5303888, 53038885, A61K 39395, C07K 1618, C07K 1622, C07K 1626
Patent
active
059938170
ABSTRACT:
Materials immunoreactive with parathyroid hormone-related protein (PTH-rp) are used in the invention method to prevent and treat cancer metastasis to bone and cancer cell growth in bone as well as osteolysis and symptomatic sequelae thereof. Antibodies with human characteristics are included in the invention for application of the invention method to human subjects.
REFERENCES:
patent: 5114843 (1992-05-01), Rosenblatt et al.
patent: 5116952 (1992-05-01), Martin et al.
patent: 5217896 (1993-06-01), Kramer et al.
patent: 5312810 (1994-05-01), Wood et al.
Tashjian, A.H. et al., "Immunochemical identification of parathyroid hormone in non-parathyroid neoplasms associatd with hypercalcemia," J. Exp. Med., 119:467-484 (1994).
Kohler, G. and Mislstein, C., "Continuous cultures of fused cells secreting antibody of predefined specificity," Nature, 256:495-497 (Aug. 1975).
Kohler, G. and Milstein, C., "Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion," Eur. J. Immunol., 6:511-519 (1976).
Eilon, G. and Mundy, G.R., Direct resorption of bone by human breast cancer cells in vitro, Nature, 276:726-728 (Dec. 1978).
Horiuchi et al., "Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro," Science, 238:1566-1568 (Dec. 1987).
Suva et al., "A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression," Science, 237:893-896, (Aug. 1987).
Yates et al., "Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents," J. Clin. Invest., 81:932-938 (Mar. 1988).
Gregory R. Mundy, "Hypercalcemia of malignancy revisited," J. Clin. Invest., 82:1-6 (Jul. 1988).
Kukreja, S.C. et al., "Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumors," J. Clin. Invest., 82:1798-1802 (Oct. 1988).
Southby et al., "Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer," Cancer Res., 50:7710-7716 (Oct. 1990).
Burton et al., "Parathyroid hormone related peptide can function as an autocrine growth factor in human renal cell carcinoma," Biochem. Biophys. Res. Comm., 167(3):1134-1138 (Mar. 1990).
Lawrence E. Mallette, "The parathyroid polyhormones: New concepts in the spectrum of peptide hormone action," Endocrine Rev., 12(2):110-117 (Feb. 1991).
Powell et al., "Localization of parathyroid hormone-related protein in breast cancer metastases: Increased incidence in bone compared with other sites," Cancer Res., 51(11):3059-3061 (Jun. 1991).
Yoneda et al., "Occurrence of hypercalcemia and leukocytosis with cachexia in a human squamous cell carcinoma of the maxilla in athymic nude mice: a novel experimental model of three concomitant paraneoplastic syndromes," J. Clin. Oncol., 9(3):468-477 (Mar. 1991).
Abou-Samra et al., "Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: A single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium," Proc. Natl. Acad. Sci. USA, 89:2732-2736 (Apr. 1992).
Nakai et al., "A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human malanoma cells in nude mice," Cancer Res., 52:5395-5399 (Oct. 1992).
Sato et al., "Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors," J. Bone Min. Res., 8(7):849-860 (Jul. 1993).
Kohno et al., "The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases," Surgery Today. Japan J. Surg. 4:215-220 (1993).
Sasaki et al., "Osteolysis and tumor growth are enhanced in sites of increased bone turnover in vivo," J. Bone Min. Res. 9(11):s194 (Nov. 1994).
Li et al., "Growth factor-like properties of parathyroid hormone-related peptide in transfected rodent cell lines," Cancer Res., 53(13):2980-2986 (Jul. 1993).
Sasaki et al., "Growth of metastatic cancer in bone is impaired by inhibitors of bone resorption in vivo," J. Bone Min. Res., 8(1):s139 (Aug. 1993).
Yoneda et al., "Development of a model of a human tumor which causes metastatic bone lesions which are mixed osteolytic and osteoblastic," J. Bone Min. Res., 9(11):s293 (Nov. 1994) (Abstract).
Guise et al., "Parathyroid hormone-related protein (PTHrP) expression by breast cancer cells enhance osteolytic bone metastases in vivo," J. Bone Min. Res., 9(11):s128 (Nov. 1994).
Gilles et al., "Cytokines stimulate interleukin-6 production in bone to a much greater extent then systemic factors," J. Bone Min. Res., 9(11):s337 (Nov. 1994).
Kukreja Endocrinology 127:305-310 1990.
Seaver Gen Eng News 14(14):10 and 21. 1994.
McClellan Endocrinology 131:2263 1992.
Oshima, Pept. Chem pp. 547-9 1992.
Harrison's "Principles of Internal Medicine" 12.sup.th edition pp. 1938-1941, 1991.
Guise Theresa A.
Mundy Gregory R.
Yoneda Toshiyuki
Field Bret
Johnson Nancy A.
Xenotech
LandOfFree
Method to ameliorate osteolysis and metastasis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to ameliorate osteolysis and metastasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to ameliorate osteolysis and metastasis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1668160